Search Within

Hollie Jaine Pegram

Formats
  1. Journal Article (13)
  2. Meeting Abstract (6)
Groups
  1. Adult Leukemia (19)
  2. Center for Hematologic Malignancies (19)
  3. Department of Medicine (19)
  4. GSK Faculty (19)
  5. Hematologic Malignancies Research (19)
  6. Hematologic Malignancies, Division of (19)

More Groups

People
  1. Renier Brentjens (19)
  2. Terence Purdon (7)
  3. Dayenne van Leeuwen (6)
  4. Kevin Curran (6)
  5. Sarwish Rafiq (6)
  6. Oladapo Yeku (4)

More People

Years
  1. 2018 (3)
  2. 2017 (1)
  3. 2016 (2)
  4. 2015 (4)
  5. 2014 (3)
  6. 2012 (2)

More Years

Publications
  1. Blood (5)
  2. Molecular Therapy (3)
  3. Cancer Research (2)
  4. Cancer Discovery (1)
  5. Immunotherapy (1)
  6. International Journal of Hematology (1)

More Publications

Publishers
  1. Nature Publishing Group (6)
  2. American Society of Hematology (5)
  3. American Association for Cancer Research (3)
  4. Cell Press (1)
  5. Future Medicine (1)
  6. John Wiley & Sons (1)

More Publishers

Results (19)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Blocking CD47 improves CAR T cell therapy
    Meeting Abstract

    Pegram, H. J.; Purdon, T. J.; Brentjens, R. J.
    Molecular Therapy (2014)

    Fulltext@MSK | Save
  • Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies
    Journal Article

    Davila, M. L.; Bouhassira, D.; Park, J. H.; Curran, K. J.; Smith, E.; Pegram, H. J.; Brentjens, R.
    International Journal of Hematology (2014)

    Fulltext@MSK | Save
  • CD28z CARs and armored CARs
    Journal Article

    Pegram, H. J.; Park, J. H.; Brentjens, R. J.
    The Cancer Journal (2014)

    Fulltext@MSK | Save
  • Chimeric antigen receptors for T cell immunotherapy: Current understanding and future directions
    Journal Article

    Curran, K. J.; Pegram, H. J.; Brentjens, R. J.
    Journal of Gene Medicine (2012)

    Fulltext@MSK | Save
  • Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
    Journal Article

    Pegram, H. J.; Lee, J. C.; Hayman, E. G.; Imperato, G. H.; Tedder, T. F.; Sadelain, M.; Brentjens, R. J.
    Blood (2012)

    Fulltext@MSK | Save
  • Tumor specific T cells modified to secrete IL-12 eradicate systemic tumors in the absence of prior toxic chemotherapy conditioning regimens
    Meeting Abstract

    Pegram, H. J.; Lee, J.; Hayman, E.; Imperato, G. H.; Tedder, T. J.; Brentjens, R. J.
    Blood (2011)

    Fulltext@MSK | Save
  • Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
    Journal Article

    Brentjens, R. J.; Riviere, I.; Park, J. H.; Davila, M. L.; Wang, X.; Stefanski, J.; Taylor, C.; Yeh, R.; Bartido, S.; Borquez-Ojeda, O.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • In vivo inhibition of human CD19-targeted effector T cells by natural T regulatory cells in a xenotransplant murine model of B cell malignancy
    Journal Article

    Lee, J. C.; Hayman, E.; Pegram, H. J.; Santos, E.; Heller, G.; Sadelain, M.; Brentjens, R.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • CD19 targeted cord blood derived T Cells for cancer immunotherapy
    Meeting Abstract

    Pegram, H. J.; LaRussa, V.; Brentjens, R.
    Blood (2010)

    Fulltext@MSK | Save